Intelligent Ultrasound Group plc
(the
"Group" or the "Company")
Notice of
results
Analyst and investor
briefing
Intelligent Ultrasound Group plc
(AIM: IUG), the 'classroom to clinic' ultrasound company
specialising in AI software and simulation, announces
it will issue its audited
final results for the year ended 31 December 2023 on Wednesday, 1
May 2024.
A briefing for analysts will be held
via Teams on 1 May 2024 at 9.30am. To register, please
contact intelligentultrasound@tbcardew.com
The Company will host a live
presentation for investors given by CEO Stuart Gall and CFO Helen
Jones via the Investor Meet Company platform on Wednesday, 1 May at
1pm. The presentation is open to all existing and potential
shareholders. Questions can be submitted pre-event via your
Investor Meet Company dashboard up until 9am the day before the
meeting or at any time during the live presentation.
Investors can sign up to Investor
Meet Company for free and add to meet the
Company via:
https://www.investormeetcompany.com/intelligent-ultrasound-group-plc/register-investor
Investors who already
follow Intelligent Ultrasound on the Investor Meet
Company platform will automatically be invited.
For further information, please
contact:
|
Intelligent Ultrasound Group plc
|
www.intelligentultrasound.com
|
|
Stuart Gall, CEO
|
Tel: +44
(0)29 2075 6534
|
|
Helen Jones, CFO
|
|
|
|
|
|
Cavendish Capital Markets Limited
(Nominated advisor and broker)
|
|
|
Giles Balleny (Corporate
Finance)
Nigel Birks (ECM)
Dale Bellis (Sales)
|
Tel: +44
(0)20 7397 8900
|
|
|
|
|
TB Cardew - PR Advisors
Ed Orlebar
|
Intelligentultrasound@tbcardew.com
Tel:
+44 (0)7738 724630
|
|
Allison Connolly
|
Tel: +44
(0)7587 453955
|
|
Emma Pascoe-Watson
|
Tel: +44
(0)7774 620415
|
|
Jessica Pilling
|
Tel: +44
(0)7918 584573
|
|
|
| |
About Intelligent Ultrasound
Group
Intelligent Ultrasound (AIM:
IUG) is one of the world's leading 'classroom to clinic' ultrasound
companies, specialising in real-time hi-fidelity virtual reality
simulation for the ultrasound training market ('classroom') and
artificial intelligence-based clinical image analysis software
tools for the diagnostic medical ultrasound market ('clinic').
Based in Cardiff in
the UK and Atlanta in the US, the Group has two
revenue streams:
Simulation
Real-time hi-fidelity ultrasound
education and training through simulation. Our main products
are the ScanTrainer obstetrics and gynaecology training
simulator, the HeartWorks echocardiography training
simulator, the BodyWorks Eve Point of Care and
Emergency Medicine training simulator with Covid-19 module and the
new BabyWorks Neonate and Paediatric training simulator. To
date over 1,700 simulators have been sold
to over 800 medical institutions around the
world.
Clinical AI software
Deep learning-based algorithms to
make ultrasound machines smarter and more accessible using our
proprietary ScanNav ultrasound image
analysis technology. Current products on the market utilising this
technology are GE
HealthCare's SonoLyst software that is incorporated in their
Voluson Expert and SWIFT ultrasound machines; ScanNav Anatomy PNB
that simplifies ultrasound-guided needling by providing the user
with real-time AI-based anatomy highlighting for a range of
medical procedures; and NeedleTrainer that teaches real-time
ultrasound-guided needling and incorporates ScanNav Anatomy
PNB.
www.intelligentultrasound.com
NOTE: ScanNav Anatomy PNB is CE
approved and cleared for sale in the US by the FDA but is not
available for sale in any other territory requiring government
approval for this type of product.